Sign In
Buy CYCC
$6.37
+0 (+0%)
At Close: Dec 10, 2025
Cyclacel Pharmaceuticals Q4 EPS $(0.17) Misses $(0.13) Estimate
12:00am, Wednesday, 26'th Feb 2020Dell to sell RSA
08:02am, Monday, 24'th Feb 2020
The company will sell its cyber security unit for $2.08 billion to a consortium led by Symphony Technology Group, Ontario Teachers’ Pension Plan Board and AlpInvest Partners.
The Week Ahead In Biotech: Biopharma Earnings Pick Up Pace
11:38pm, Sunday, 23'rd Feb 2020
Biotech stocks turned in a lackadaisical performance last week amid earnings releases by smid-cap stocks, a few clinical readouts and data presentations at conferences and a handful of FDA verdicts. M
The Week Ahead In Biotech: Biopharma Earnings Pick Up Pace
12:00am, Sunday, 23'rd Feb 2020Cyclacel (CYCC) to Report Q4 Earnings: What's in the Cards?
01:50pm, Thursday, 20'th Feb 2020
We expect Cyclacel (CYCC) to provide updates on its pipeline when it releases fourth-quarter 2019 results.
Cyclacel (CYCC) to Report Q4 Earnings: What's in the Cards?
01:50pm, Thursday, 20'th Feb 2020
We expect Cyclacel (CYCC) to provide updates on its pipeline when it releases fourth-quarter 2019 results.
Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2019 Financial Results
12:00pm, Wednesday, 19'th Feb 2020
BERKELEY HEIGHTS, N.J., Feb. 19, 2020 -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing.
Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year —…–9 Financial Results
12:00am, Wednesday, 19'th Feb 2020Is Cyclacel Pharmaceuticals, Inc.'s (NASDAQ:CYCC) CEO Paid At A Competitive Rate?
01:53pm, Monday, 10'th Feb 2020
In 1997 Spiro Rombotis was appointed CEO of Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC). This report will, first...
Cyclacel Pharmaceuticals to Present at the 2020 BIO CEO & Investor Conference
12:00pm, Monday, 03'rd Feb 2020
Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC, Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, announces that the
Cyclacel Pharmaceuticals to Present at the —…—… BIO CEO & Investor Conference
12:00am, Monday, 03'rd Feb 2020Cyclacel Pharmaceuticals Reviews 2019 Achievements and Announces Key Business Objectives for 2020
12:00pm, Monday, 13'th Jan 2020
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today provided a bu
